BGM
IMNM icon

Burkehill Global Management’s Immunome IMNM Stock Holding History

Burkehill Global Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.37M Hold
200,000
– – 0.22% 80
2025
Q4 		$4.3M Buy
+200,000
New +$3.51M 0.28% 84

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Burkehill Global Management's IMNM Position: Q1 2026 in Review

Burkehill Global Management held its Immunome (IMNM) position steady in Q1 2026 at 200,000 shares worth $4.37M. The position accounts for 0.22% of the portfolio, ranked #80.

Burkehill Global Management first reported a position in IMNM in Q4 2025 and has held it in 2 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Burkehill Global Management held 200,000 shares of Immunome worth $4.37M as of Q1 2026.
  • Burkehill Global Management left its Immunome share count unchanged in Q1 2026.
  • Immunome made up 0.22% of Burkehill Global Management's portfolio in Q1 2026, its #80 holding.
  • Burkehill Global Management first reported a position in Immunome in Q4 2025 and has held it in 2 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.